-
- 抗原 See all IFNA2 抗体
- IFNA2 (Interferon, alpha 2 (IFNA2))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This IFNA2 antibody is un-conjugated
-
应用范围
- Immunofluorescence (IF), Flow Cytometry (FACS)
- 原理
- Mouse monoclonal antibody raised against full length recombinant human IFNA2.
- 交叉反应
- 人
- 免疫原
- Recombinant protein corresponding to full length human IFNA2.
- 克隆位点
- N27
- 亚型
- IgG1
- Top Product
- Discover our top product IFNA2 Primary Antibody
-
-
- 应用备注
-
Flow Cytometry (0.5-1 μg/106 cells)
Immunofluorescence (0.5-1 μg/mL)
The optimal working dilution should be determined by the end user. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- In 10 mM PBS (0.05 % BSA, 0.05 % sodium azide).
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
- 储存方法
- Store at 4°C.
-
-
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2." in: Immunology letters, Vol. 35, Issue 3, pp. 281-4, (1993) (PubMed).
: "Mapping of two immunodominant structures on human interferon alpha 2c and their role in binding to cells." in: Molecular immunology, Vol. 28, Issue 11, pp. 1289-97, (1992) (PubMed).
: "Interferons and their actions." in: Annual review of biochemistry, Vol. 56, pp. 727-77, (1987) (PubMed).
: "
-
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2." in: Immunology letters, Vol. 35, Issue 3, pp. 281-4, (1993) (PubMed).
-
- 抗原
- IFNA2 (Interferon, alpha 2 (IFNA2))
- 别名
- IFNA2 (IFNA2 产品)
- 别名
- IFN-alphaA antibody, IFNA antibody, IFNA2B antibody, INFA2 antibody, Ifa2 antibody, IFNA2 antibody, interferon alpha 2 antibody, interferon, alpha 2 antibody, interferon-alpha-2 antibody, interferon alpha-2 antibody, IFNA2 antibody, Ifna2 antibody, ifna2 antibody, IFN-ALPHA2 antibody, LOC102142148 antibody
- 背景
-
Full Gene Name: interferon, alpha 2
Synonyms: IFNA,INFA2,MGC125764,MGC125765 - 基因ID
- 3440
- 途径
- JAK/STAT Signaling, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
-